EBIKA MBUAGBAW: Open Payments
NPI 1194335240 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 3 payments from 3 companies in 2025. Trend: 2023 $372 · 2024 $577 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Luye Pharma (USA) Ltd. | 1 | $90 |
Products named: REXULTI, CAPLYTA, ERZOFRI EXTENDED-RELEASE.
Industry payments across TX — which companies pay providers there.
